WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Trading Down 7% – Here’s Why

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) fell 7% on Thursday . The company traded as low as $8.23 and last traded at $8.25. 9,615 shares changed hands during trading, a decline of 87% from the average session volume of 75,649 shares. The stock had previously closed at $8.8740.

WuXi Biologics (Cayman) Stock Performance

The business has a fifty day simple moving average of $8.65 and a two-hundred day simple moving average of $8.95.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.